TScan Therapeutics, Inc. (TCRX)
1.25
+0.04
(+3.31%)
USD |
NASDAQ |
May 06, 16:00
1.29
+0.04
(+3.20%)
After-Hours: 20:00
TScan Therapeutics Total Liabilities (Quarterly) : 105.67M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Lexicon Pharmaceuticals, Inc. | 77.45M |
| Agios Pharmaceuticals, Inc. | 75.88M |
| Sutro Biopharma, Inc. | 306.28M |
| Recursion Pharmaceuticals, Inc. | 397.49M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 228.79M |
| Shareholders Equity (Quarterly) | 123.12M |
| Debt to Equity Ratio | 0.7646 |
| Current Ratio | 8.409 |
| Net Debt Paydown Yield | -1.33% |